Skip to content
← Full study record

NCT03370276 · MORE INFO

Limitations, agreements, and source contact

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · Source last updated 2026-04-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
The rights to publish the results of the study are vested in Moffitt. Subsite is free to publish any academic article, presentation or abstracts of the study results (including supporting data) twelve months after the conclusion or termination of the study provided that any such manuscript is first submitted to Moffitt sixty days prior to the proposed publication date.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
Christine.Chung@moffitt.org
organization
Moffitt Cancer Center
phone
813-745-5061
title
Christine Chung, MD
Complete source fields
certain Agreement
other Details
The rights to publish the results of the study are vested in Moffitt. Subsite is free to publish any academic article, presentation or abstracts of the study results (including supporting data) twelve months after the conclusion or termination of the study provided that any such manuscript is first submitted to Moffitt sixty days prior to the proposed publication date.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
Christine.Chung@moffitt.org
organization
Moffitt Cancer Center
phone
813-745-5061
title
Christine Chung, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice